Polycyclic aromatic hydrocarbon exposure in oesophageal tissue and risk of oesophageal squamous cell carcinoma in north-eastern Iran

Gut

Volumn 59, Issue 9, 2010, Pages 1178-1183

  Abedi Ardekani, Behnoush ^a,b,c,d   Kamangar, Farin ^a,b,e   Hewitt, Stephen M ^b   Hainaut, Pierre ^c   Sotoudeh, Masoud ^a   Abnet, Christian C ^b   Taylor, Philip R ^b   Boffetta, Paolo ^c,f   Malekzadeh, Reza ^a   Dawsey, Sanford M ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NATIONAL CANCER INSTITUTE   (United States)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d Social Security Organization   (Iran)

^e MORGAN STATE UNIVERSITY   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; GUANOSINE; POLYCYCLIC AROMATIC HYDROCARBON;

ADULT; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DNA MODIFICATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS; ESOPHAGUS BIOPSY; ESOPHAGUS MUCOSA; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IRAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TISSUE MICROARRAY; BIOPSY; CASE CONTROL STUDY; CHEMICALLY INDUCED; CHEMISTRY; DOSE RESPONSE; ESOPHAGUS TUMOR; IMAGE PROCESSING; MIDDLE AGED; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TOXICITY; TUMOR CELL CULTURE;

ADULT; AGED; BIOPSY; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; POLYCYCLIC HYDROCARBONS, AROMATIC; TUMOR CELLS, CULTURED;

EID: 77956131002     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2010.210609     Document Type: Article

References (34)

1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006;24:2137-50. (Pubitemid 46655601)
2. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
3. Mahboubi E, Kmet J, Cook PJ, et al. Oesophageal cancer studies in the Caspian Littoral of Iran: the Caspian cancer registry. Br J Cancer 1973;28:197-214.
4. Semnani S, Sadjadi A, Fahimi S, et al. Declining incidence of esophageal cancer in the Turkmen Plain, eastern part of the Caspian Littoral of Iran: a retrospective cancer surveillance. Cancer Detect Prev 2006;30:14-19.
5. Engel LS, Chow WH, Vaughan TL, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 2003;95:1404-13.
6. Freedman ND, Abnet CC, Leitzmann MF, et al. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol 2007;165:1424-33.
7. Nasrollahzadeh D, Kamangar F, Aghcheli K, et al. Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer 2008;98:1857-63.
8. Tran GD, Sun XD, Abnet CC, et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 2005;113:456-63.
9. Pourshams A, Khademi H, Malekshah AF, et al. Cohort profile: the Golestan Cohort Studyda prospective study of oesophageal cancer in northern Iran. Int J Epidemiol 2009;39:52-9.
10. Qiao YL, Dawsey SM, Kamangar F, et al. Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer Inst 2009;101:507-18.
11. Islami F, Pourshams A, Nasrollahzadeh D, et al. Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ 2009;338:b929.
12. Abnet CC, Qiao YL, Dawsey SM, et al. Tooth loss is associated with increased risk of total death and death from upper gastrointestinal cancer, heart disease, and stroke in a Chinese population-based cohort. Int J Epidemiol 2005;34:467-74.
13. Abnet CC, Kamangar F, Islami F, et al. Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2008;17:3062-8.
14. Kmet J, Mahboubi E. Esophageal cancer in the Caspian littoral of Iran: initial studies. Science 1972;175:846-53.
15. Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 2003;3:733-44.
16. Kazerouni N, Sinha R, Hsu CH, et al. Analysis of 200 food items for benzo[a]pyrene and estimation of its intake in an epidemiologic study. Food Chem Toxicol 2001;39:423-36.
17. Chang KF, Fang GC, Chen JC, et al. Atmospheric polycyclic aromatic hydrocarbons (PAHs) in Asia: a review from 1999 to 2004. Environ Pollut 2006;142:388-96.
18. Mastrangelo G, Fadda E, Marzia V. Polycyclic aromatic hydrocarbons and cancer in man. Environ Health Perspect 1996;104:1166-70. (Pubitemid 27028848)
19. Straif K, Baan R, Grosse Y, et al. Carcinogenicity of polycyclic aromatic hydrocarbons. Lancet Oncol 2005;6:931-2.
20. Hakami R, Mohtadinia J, Etemadi A, et al. Dietary intake of benzo(a)pyrene and risk of esophageal cancer in north of Iran. Nutr Cancer 2008;60:216-21.
21. Kamangar F, Strickland PT, Pourshams A, et al. High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal cancer in northeastern Iran. Anticancer Res 2005;25:425-8.
22. Islami F, Kamangar F, Nasrollahzadeh D, et al. Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area. Int J Epidemiol 2009;38:978-88.
23. Santella RM, Lin CD, Cleveland WL, et al. Monoclonal antibodies to DNA modified by a benzo[a]pyrene diol epoxide. Carcinogenesis 1984;5:373-7.
24. Santella RM, Hsieh LL, Lin CD, et al. Quantitation of exposure to benzo[a]pyrene with monoclonal antibodies. Environ Health Perspect 1985;62:95-9.
25. Santella RM, Lin CD, Dharmaraja N. Monoclonal antibodies to a benzo[a]pyrene diolepoxide modified protein. Carcinogenesis 1986;7:441-4. (Pubitemid 17135323)
26. Strickland PT, Kang D, Bowman ED, et al. Identification of 1-hydroxypyrene glucuronide as a major pyrene metabolite in human urine by synchronous fluorescence spectroscopy and gas chromatography-mass spectrometry. Carcinogenesis 1994;15:483-7.
27. Nesnow S, Ross J, Nelson G, et al. Quantitative and temporal relationships between DNA adduct formation in target and surrogate tissues: implications for biomonitoring. Environ Health Perspect 1993;101(Suppl 3):37-42.
28. Pott P. Chirurgical observations. Natl Cancer Inst Monogr 1963;10:7.
29. Strickland P, Kang D, Sithisarankul P. Polycyclic aromatic hydrocarbon metabolites in urine as biomarkers of exposure and effect. Environ Health Perspect 1996;104(Suppl 5):927-32. (Pubitemid 26402332)
30. Poirier MC, Santella RM, Weston A. Carcinogen macromolecular adducts and their measurement. Carcinogenesis 2000;21:353-9.
31. van Gijssel HE, Schild LJ, Watt DL, et al. Polycyclic aromatic hydrocarbon-DNA adducts determined by semiquantitative immunohistochemistry in human esophageal biopsies taken in 1985. Mutat Res 2004;547:55-62.
32. Pratt MM, Sirajuddin P, Poirier MC, et al. Polycyclic aromatic hydrocarbon-DNA adducts in cervix of women infected with carcinogenic human papillomavirus types: an immunohistochemistry study. Mutat Res 2007;624:114-23.
33. John K, Ragavan N, Pratt MM, et al. Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate. Prostate 2009;69:505-19.
34. Abnet CC, Saadatian-Elahi M, Pourshams A, et al. Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. Cancer Epidemiol Biomarkers Prev 2004;13:1068-70.